** Shares of medical device maker Zimmer Biomet Holdings ZBH.N fall 3.8% to $89 premarket
** Co raises annual adjusted profit forecast to $8.40–$8.55/shr vs prior view of $8.30–$8.45
** New range compares with analysts' average estimate of $8.40/shr – LSEG
** Co reports Q1 adjusted EPS of $2.09/shr vs analysts' average estimate of $1.86/shr – LSEG
** Reports Q1 revenue of $2.087 bln vs analysts' average estimate of $2.07 bln – LSEG
** Separately, co says CFO Suketu Upadhyay will leave for another professional opportunity, with Controller and Chief Accounting Officer Paul Stellato named interim finance chief
** As of last close, stock was up ~3% YTD
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))